Emergency BU Alert Boston University's Charles River and Medical Center Campuses will be closing today, Monday, January 26, 2015 at 5:00 PM and will be closed all day Tuesday, January 27, 2015. All normal academic and administrative activities (e.g. classes, seminars and meetings) that are scheduled to take place after 5:00 PM on Monday are cancelled. When classes resume, they will resume on the regular class schedule. Whether or how classes are to be made up is at the discretion of the faculty member. For detailed information about the Boston University Medical campus, please go to http://www.bu.edu/ehs/comm Please note: Employees in essential services must report as scheduled. Essential services include, but are not limited to, University Police, Public Safety, Emergency Patient Treatment, Facilities Management and Planning, Environmental Health & Safety, University Dining Services, Mail Services, Student Health Services and the University Switchboard. For the very latest information, please go to http://www.bu.edu/today

Mahasweta Girgenrath

girgenrath-mahaswetaAssistant Professor of Medicine


Northeastern University- Ph.D in Biology

General Field of Work:

Biomedical Science

Affiliations other than medicine:

Department of Health Science

College of Health and Rehabilitation Science

Boston University

Lab Members:

Ajay Kumar, postdoctoral fellow


Contact information:


635 Commonwealth Ave, Boston MA-02053

Phone: (617)-353-2739

Email: swetag@bu.edu


Skeletal Muscle, Muscular Dystrophy, Muscle Regeneration

Summary of academic interest:

My research program uses a combination of molecular, cellular and in vivo techniques to understand the mechanisms that underlie tissue growth, repair, and survival in the context of neuromuscular diseases such as muscular dystrophy. My long-term goal is to translate the findings into the development of effective treatment and cures for damaged or diseased muscle.

Recent Publications:

Girgenrath, M., Beermann, M. L, Vishnudas, V., Homma, S. and Miller, J. B. (2008). Pathology is alleviated by doxycycline in a laminin-a2 null model of MDC1A. Annals of Neurology.

Technologies available for sharing upon request:

Morphometrics, Quantitative PCR, Protein Biochemistry